Capstone Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 31,500 shares of VRTX stock, worth $14.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

31,500

Previous 26,100 20.69%

Holding current value

$14.6 Million

Previous $12.2 Million 19.76%

% of portfolio

0.05%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $400,200 - $440,028	870 New	870 $404,000
Q1 2024 May 01, 2024	BUY	$407.69 - $446.08 $1.23 Million - $1.34 Million	3,013 Added 223.85%	4,359 $1.82 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $461,678 - $552,775	1,346 New	1,346 $547,000
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $593,083 - $676,571	2,094 Added 216.1%	3,063 $965,000
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $276,901 - $311,514	969 New	969 $279,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $280,072 - $348,719	1,192 Added 119200.0%	1,193 $336,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $2.67 Million - $3.15 Million	-12,059 Reduced 99.99%	1 $0
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $15.8 Million - $19.9 Million	-89,256 Reduced 88.1%	12,060 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $12 Million - $13.4 Million	65,894 Added 186.03%	101,316 $18.4 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $4.28 Million - $5.04 Million	22,814 Added 180.95%	35,422 $7.14 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $4.03 Million - $4.7 Million	-19,479 Reduced 60.71%	12,608 $2.71 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $6.61 Million - $8.82 Million	31,929 Added 20208.23%	32,087 $7.58 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $868,385 - $977,358	-5,224 Reduced 97.06%	158 $27,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $93,004 - $107,559	-565 Reduced 9.5%	5,382 $987,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $947,832 - $1.13 Million	5,789 Added 3663.92%	5,947 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $264,931 - $335,214	-1,744 Reduced 91.69%	158 $26,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $319,022 - $366,591	1,902 New	1,902 $367,000
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $356,928 - $404,430	-2,600 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $385,138 - $421,824	2,600	2,600 $395,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History